Partnering with GammaDelta Therapeutics

GammaDelta Therapeutics is building partnerships with prestigious research institutions, experts in immune therapy and life science investors.

Strategic partners

Additional areas of interest

Whereas we are focussed on exploring Vδ1+ T cell based cell therapy of cancer, we have gained tremendous insight into Vδ1+ T cell cell biology through our own studies and from our collaborators. These insights have resulted in identification of a number of targets for exploitation via molecular agents. We are actively pursuing such targets via collaboration with Adaptate Biotherapeutics and other external third parties.

Contact us